Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,707 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,707 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Enrollment posture brief
Registry condition cancer
OPEN 279 | RECR 45% | LATE 31 | EARLY 164 | RANK #6 | SPON 31
Volume-matched condition peers
Nearest open-share peer: Duchenne Muscular Dystrophy (45% recruiting · 49 trials)
Cancer lists 279 open slots (45% of 621 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 6 of 13
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06858449
Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06610396
Trial of DFP-14927 in Advanced Solid Tumors
Delta-Fly Pharma
NCT03943004
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
M.D. Anderson Cancer Center
NCT06434402
Evaluating the Communication Between Patients and Providers in Cancer Clinics
University of Wisconsin, Madison
NCT06985953
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
Dartmouth-Hitchcock Medical Center
NCT05302375
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
University of Arizona
NCT06644560
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
University of Maryland, Baltimore
NCT06248216
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Aadi Bioscience
NCT05997017
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
University of Miami
NCT06952790
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
M.D. Anderson Cancer Center
NCT07298096
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Stanford University
NCT07220343
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
Medstar Health Research Institute
NCT07228377
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
Mayo Clinic
NCT07221409
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
M.D. Anderson Cancer Center
NCT06801041
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
Yale University
NCT07019259
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
M.D. Anderson Cancer Center
NCT05694650
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
Sunstone Medical
NCT05584826
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Massachusetts General Hospital
NCT06172907
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Icahn School of Medicine at Mount Sinai
NCT04615988
The Gut Microbiome and Immunotherapy Response in Solid Cancers
The University of Texas Medical Branch, Galveston
NCT06050733
Daily Hand-Held Vibration Therapy
Indiana University
NCT04207437
Digital Art Therapy for Young Cancer Survivors
UNC Lineberger Comprehensive Cancer Center
NCT06789666
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT07023887
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Children's Hospital of Philadelphia
NCT06458036
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
NCT05783323
FAMILY Sleep Program
University of Miami
NCT06571305
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
M.D. Anderson Cancer Center
NCT06807593
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
University of Pittsburgh
NCT04452305
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
National Cancer Institute (NCI)
NCT04750915
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
National Cancer Institute (NCI)
NCT00339495
PATHFINDER 2: a Multi-Cancer Early Detection Study
GRAIL
NCT05155605
Gulf Long-Term Follow-Up Study
National Institute of Environmental Health Sciences (NIEHS)
NCT01287000
Vitamin D and Omega-3 Trial (VITAL)
Brigham and Women's Hospital
NCT01169259
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Anne Murray
NCT07224347
REFLECTION: A Clinical Practice Learning Program for Galleri®
GRAIL
NCT05205967
The Biorepository for Scripps Health
Scripps Translational Science Institute
NCT01006239
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
National Cancer Institute (NCI)
NCT00001163
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
Memorial Sloan Kettering Cancer Center
NCT03208374
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
Sunnybrook Health Sciences Centre
NCT02261415
Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center
NCT00587886
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Hoffmann-La Roche
NCT03768063
Patient-Reported Outcome Version of the Common Criteria for Adverse Events
St. Jude Children's Research Hospital
NCT04050072
Enhancing Cancer Care Of Rural Dwellers
Debra Friedman
NCT04758338
Patient Navigation 2.0
Northwestern University
NCT04234646
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
M.D. Anderson Cancer Center
NCT05436327
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Abramson Cancer Center at Penn Medicine
NCT04774445
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Invitae Corporation
NCT05219734
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Hoffmann-La Roche
NCT03148418
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
Memorial Sloan Kettering Cancer Center
NCT01579552
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer page
621 registered trials, 279 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 279 Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Cancer trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer condition card totals 621 registered trials; most-linked intervention Usual Care; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.